Prenetics Global (PRE) Cash & Equivalents (2020 - 2026)

Prenetics Global (PRE) has reported Cash & Equivalents for 7 consecutive years, with $59.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cash & Equivalents rose 242.34% year-over-year to $59.0 million in Q2 2026; TTM through Jun 2026 was $59.0 million, a 242.34% increase from a year earlier, with the FY2025 full-year figure at $32.1 million, down 38.51% from the prior year.
• Cash & Equivalents was $59.0 million for Q2 2026 at Prenetics Global, up from $56.0 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $177.2 million in Q2 2023 and troughed at $7.8 million in Q4 2025.
• A 5-year average of $71.0 million and a median of $51.8 million in 2024 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents jumped 385.7% in 2023 and tumbled 84.03% in 2025, its largest moves.
• Over 5 years, Cash & Equivalents stood at $146.7 million in 2022, then slumped by 68.84% to $45.7 million in 2023, then climbed by 7.54% to $49.2 million in 2024, then plunged by 84.03% to $7.8 million in 2025, then jumped by 652.5% to $59.0 million in 2026.
• The last three Cash & Equivalents figures came in at $59.0 million (Q2 2026), $56.0 million (Q1 2026), and $7.8 million (Q4 2025), per Business Quant data.